(S (NP (JJ Glycemic) (NN control)) (VP (VBZ is) (ADJP (JJ essential) (PP (IN for) (NP (JJ critical) (NN care))))) (. .))
(S (ADVP (RB However)) (, ,) (NP (PRP it)) (VP (VBZ is) (NP (DT a) (JJ challenging) (NN task)) (SBAR (IN because) (S (NP (EX there)) (VP (VBZ has) (VP (VBN been) (NP (NP (DT no) (NN study)) (PP (IN on) (NP (NP (VBN personalized) (JJ optimal) (NNS strategies)) (PP (IN for) (NP (JJ glycemic) (NN control))))))))))) (. .))
(S (NP (DT This) (NN work)) (VP (VBZ aims) (S (VP (TO to) (VP (VB learn) (NP (VBN personalized) (JJ optimal) (JJ glycemic) (NNS trajectories)) (PP (IN for) (NP (NML (ADJP (RB severely) (JJ ill)) (NN septic)) (NNS patients))) (PP (IN by) (S (VP (VBG learning) (NP (UCP (NML (NNS data)) (HYPH -) (ADJP (VBN driven))) (NNS policies)) (S (VP (TO to) (VP (VB identify) (NP (JJ optimal) (VBN targeted) (NML (NN blood) (NN glucose)) (NNS levels)) (PP (IN as) (NP (NP (DT a) (NN reference)) (PP (IN for) (NP (NNS clinicians))))))))))))))) (. .))
(S (NP (PRP We)) (VP (VP (VBD encoded) (NP (JJ patient) (NNS states)) (S (VP (VBG using) (NP (DT a) (JJ sparse) (NN autoencoder))))) (CC and) (VP (VBD adopted) (NP (DT a) (NN reinforcement)) (S (VP (VBG learning) (NP (NN paradigm)) (S (VP (VBG using) (NP (NN policy) (NN iteration)) (S (VP (TO to) (VP (VB learn) (NP (DT the) (JJ optimal) (NN policy)) (PP (IN from) (NP (NNS data)))))))))))) (. .))
(S (NP (PRP We)) (ADVP (RB also)) (VP (VBD estimated) (SBAR (S (NP (NP (DT the) (VBN expected) (NN return)) (PP (VBG following) (NP (DT the) (NN policy)))) (VP (VBD learned) (PP (IN from) (NP (NP (DT the) (VBN recorded) (JJ glycemic) (NNS trajectories)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD yielded) (NP (DT a) (NN function)) (S (VP (VBG indicating) (NP (NP (DT the) (NN relationship)) (PP (IN between) (NP (NP (NML (JJ real) (NN blood) (NN glucose)) (NNS values)) (CC and) (NP (NML (CD 90) (HYPH -) (NN day)) (NN mortality) (NNS rates)))))))))))))))) (. .))
(S (NP (DT This)) (VP (VBZ suggests) (SBAR (IN that) (S (NP (NP (DT the)) (VP (VBN learned) (NP (JJ optimal) (NN policy)))) (VP (MD could) (VP (VB reduce) (NP (NP (DT the) (NNS patients) (POS ')) (VBN estimated) (NML (CD 90) (HYPH -) (NN day)) (NN mortality) (NN rate)) (PP (IN by) (NP (CD 6.3) (NN %))) (, ,) (PP (IN from) (NP (QP (CD 31) (NN %) (IN to) (CD 24.7) (NN %))))))))) (. .))
(S (NP (DT The) (NN result)) (VP (VBZ demonstrates) (SBAR (IN that) (S (NP (NP (NN reinforcement)) (VP (VBG learning) (PP (IN with) (NP (NP (JJ appropriate) (JJ patient) (NN state)) (VP (VBG encoding)))))) (VP (MD can) (ADVP (RB potentially)) (VP (VP (VB provide) (NP (JJ optimal) (JJ glycemic) (NNS trajectories))) (CC and) (VP (VB allow) (NP (NNS clinicians)) (S (VP (TO to) (VP (VB design) (NP (NP (DT a) (VBN personalized) (NN strategy)) (PP (IN for) (NP (JJ glycemic) (NML (NN control) (IN in) (NN septic)) (NNS patients))))))))))))) (. .))
